These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7489494)

  • 1. Inhibition of the hammerhead ribozyme by neomycin.
    Stage TK; Hertel KJ; Uhlenbeck OC
    RNA; 1995 Mar; 1(1):95-101. PubMed ID: 7489494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neomycin inhibition of the hammerhead ribozyme involves ionic interactions.
    Clouet-d'Orval B; Stage TK; Uhlenbeck OC
    Biochemistry; 1995 Sep; 34(35):11186-90. PubMed ID: 7669776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic interactions with the hammerhead ribozyme:tetracyclines as a new class of hammerhead inhibitor.
    Murray JB; Arnold JR
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):855-60. PubMed ID: 8760373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics.
    Rogers J; Chang AH; von Ahsen U; Schroeder R; Davies J
    J Mol Biol; 1996 Jun; 259(5):916-25. PubMed ID: 8683594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the antibiotics neomycin B and chlortetracycline with the hammerhead ribozyme as studied by Zn2+-dependent RNA cleavage.
    Borda EJ; Sigurdsson ST
    Bioorg Med Chem; 2004 Mar; 12(5):1023-8. PubMed ID: 14980615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic and thermodynamic analysis of cleavage site mutations in the hammerhead ribozyme.
    Baidya N; Uhlenbeck OC
    Biochemistry; 1997 Feb; 36(5):1108-14. PubMed ID: 9033401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of intermolecular cleavage by hammerhead ribozymes.
    Fedor MJ; Uhlenbeck OC
    Biochemistry; 1992 Dec; 31(48):12042-54. PubMed ID: 1280996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conformational change in the catalytic core of the hammerhead ribozyme upon cleavage of an RNA substrate.
    Simorre JP; Legault P; Hangar AB; Michiels P; Pardi A
    Biochemistry; 1997 Jan; 36(3):518-25. PubMed ID: 9012667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence requirements of the hammerhead RNA self-cleavage reaction.
    Ruffner DE; Stormo GD; Uhlenbeck OC
    Biochemistry; 1990 Nov; 29(47):10695-702. PubMed ID: 1703005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technology.
    Jenne A; Hartig JS; Piganeau N; Tauer A; Samarsky DA; Green MR; Davies J; Famulok M
    Nat Biotechnol; 2001 Jan; 19(1):56-61. PubMed ID: 11135553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA.
    Hermann T; Westhof E
    J Mol Biol; 1998 Mar; 276(5):903-12. PubMed ID: 9566195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic structures of the hammerhead ribozyme: relationship to ribozyme folding and catalysis.
    Wedekind JE; McKay DB
    Annu Rev Biophys Biomol Struct; 1998; 27():475-502. PubMed ID: 9646875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hammerhead ribozymes with a faster cleavage rate.
    Clouet-d'Orval B; Uhlenbeck OC
    Biochemistry; 1997 Jul; 36(30):9087-92. PubMed ID: 9254134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators.
    Jankowsky E; Schwenzer B
    Biochemistry; 1996 Dec; 35(48):15313-21. PubMed ID: 8952482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular substrates of the hammerhead ribozyme shift the internal equilibrium further toward cleavage.
    Stage-Zimmermann TK; Uhlenbeck OC
    Biochemistry; 1998 Jun; 37(26):9386-93. PubMed ID: 9649320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the interactions of selected antibiotics and their Cu2+ complexes with the antigenomic δ ribozyme.
    Wrzesinski J; Błaszczyk L; Wrońska M; Kasprowicz A; Stokowa-Sołtys K; Nagaj J; Szafraniec M; Kulinski T; Jeżowska-Bojczuk M; Ciesiołka J
    FEBS J; 2013 Jun; 280(11):2652-64. PubMed ID: 23527582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase.
    Yokoyama Y; Wan X; Takahashi Y; Shinohara A; Liulin T; Tamaya T
    Arch Biochem Biophys; 2002 Sep; 405(1):32-7. PubMed ID: 12176054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hammerheads derived from sTRSV show enhanced cleavage and ligation rate constants.
    Nelson JA; Shepotinovskaya I; Uhlenbeck OC
    Biochemistry; 2005 Nov; 44(44):14577-85. PubMed ID: 16262257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-dependent change in the rate-determining step in a reaction catalyzed by a hammerhead ribozyme.
    Takagi Y; Taira K
    FEBS Lett; 1995 Mar; 361(2-3):273-6. PubMed ID: 7698337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic characterization of two I/II format hammerhead ribozymes.
    Clouet-D'Orval B; Uhlenbeck OC
    RNA; 1996 May; 2(5):483-91. PubMed ID: 8665415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.